CY1659A - Sulfonyl ureas with anti-tumour activity - Google Patents

Sulfonyl ureas with anti-tumour activity

Info

Publication number
CY1659A
CY1659A CY1659A CY165993A CY1659A CY 1659 A CY1659 A CY 1659A CY 1659 A CY1659 A CY 1659A CY 165993 A CY165993 A CY 165993A CY 1659 A CY1659 A CY 1659A
Authority
CY
Cyprus
Prior art keywords
tumour activity
sulfonyl ureas
ureas
sulfonyl
tumour
Prior art date
Application number
CY1659A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY1659A publication Critical patent/CY1659A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY1659A 1985-09-23 1993-05-14 Sulfonyl ureas with anti-tumour activity CY1659A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77935485A 1985-09-23 1985-09-23
US88867586A 1986-07-24 1986-07-24

Publications (1)

Publication Number Publication Date
CY1659A true CY1659A (en) 1993-05-14

Family

ID=27119572

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1659A CY1659A (en) 1985-09-23 1993-05-14 Sulfonyl ureas with anti-tumour activity

Country Status (21)

Country Link
EP (1) EP0222475B1 (fr)
JP (1) JPH0662548B2 (fr)
KR (1) KR880000204B1 (fr)
CN (1) CN1013198B (fr)
AU (1) AU587064B2 (fr)
CY (1) CY1659A (fr)
DE (1) DE3667168D1 (fr)
DK (1) DK160981C (fr)
EG (1) EG18046A (fr)
ES (1) ES2001698A6 (fr)
GR (1) GR862353B (fr)
HK (1) HK88692A (fr)
HU (1) HU200597B (fr)
IE (1) IE59588B1 (fr)
IL (1) IL80032A (fr)
MX (1) MX9203126A (fr)
NZ (1) NZ217597A (fr)
PT (1) PT83389B (fr)
SG (1) SG66892G (fr)
SU (1) SU1545939A3 (fr)
UA (1) UA5953A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
CA1331464C (fr) * 1987-05-12 1994-08-16 Eli Lilly And Company Methode et composes antitumoraux
HU202487B (en) * 1988-03-04 1991-03-28 Mta Koezponti Kemiai Kutato In Process for producing n-sulfonylureas
US5216026A (en) * 1990-07-17 1993-06-01 Eli Lilly And Company Antitumor compositions and methods of treatment
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5262440A (en) * 1991-12-10 1993-11-16 Eli Lilly And Company Antitumor compositions and methods of treatment
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
US5234955A (en) * 1991-12-20 1993-08-10 Eli Lilly And Company Antitumor compositions and methods of treatment
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (fr) * 1992-12-10 1994-06-11 Gerald Burr Grindey Compositions antitumorales et methodes de traitement
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
EP1342697A3 (fr) * 1996-08-07 2004-05-06 Tomita Pharmaceutical Co., Ltd. Méthode de traitement des eaux usées
CN1079096C (zh) * 1996-08-22 2002-02-13 同和药品工业株式会社 用作抗肿瘤剂的芳磺酰基咪唑啉酮衍生物
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
WO2006030947A1 (fr) * 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. Utilisation conjointe d’un compose a base de sulfonamide et d'un inhibiteur d’angiogenese
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
ME01222B (me) * 2005-02-28 2013-06-20 Eisai R&D Man Co Ltd Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera
KR20070114774A (ko) * 2005-02-28 2007-12-04 에자이 알앤드디 매니지먼트 가부시키가이샤 술폰아미드 화합물의 혈관 신생 저해 물질과의 신규 병용
WO2006090932A1 (fr) * 2005-02-28 2006-08-31 Eisai R & D Managemant Co., Ltd. Marqueur de substitution pour compose de sulfonamide
EP2015070A4 (fr) 2006-04-20 2010-04-21 Eisai R&D Man Co Ltd Nouveau marqueur contre la sensibilité à un composé de sulfonamide
JP2012136435A (ja) * 2009-03-30 2012-07-19 Eisai R & D Management Co Ltd 腫瘍組織の感受性を検査する方法
CN102993106B (zh) * 2012-12-24 2015-06-17 武汉武药制药有限公司 格列吡嗪的合成新路线
GB201618240D0 (en) * 2016-10-27 2016-12-14 Trade Vehicle Locks Ltd Apparatus for locking a door of a vehicle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
DE1159937B (de) * 1960-06-29 1963-12-27 Heyden Chem Fab Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
IT1161220B (it) * 1983-04-21 1987-03-18 Montedison Spa Diidro-benzofurano derivati ad attivita' erbicida
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides

Also Published As

Publication number Publication date
NZ217597A (en) 1989-06-28
EP0222475B1 (fr) 1989-11-29
JPS6296459A (ja) 1987-05-02
KR870003086A (ko) 1987-04-15
IE59588B1 (en) 1994-03-09
KR880000204B1 (ko) 1988-03-12
DK446986D0 (da) 1986-09-18
DK160981C (da) 1991-10-28
HUT46657A (en) 1988-11-28
DK446986A (da) 1987-03-24
DE3667168D1 (de) 1990-01-04
AU6294286A (en) 1987-03-26
SG66892G (en) 1992-09-04
IE862503L (en) 1987-03-23
PT83389B (pt) 1989-05-12
EG18046A (en) 1991-08-30
HK88692A (en) 1992-11-20
MX9203126A (es) 1992-07-01
IL80032A (en) 1992-07-15
HU200597B (en) 1990-07-28
CN86106428A (zh) 1987-03-18
AU587064B2 (en) 1989-08-03
SU1545939A3 (ru) 1990-02-23
GR862353B (en) 1987-01-19
DK160981B (da) 1991-05-13
EP0222475A1 (fr) 1987-05-20
JPH0662548B2 (ja) 1994-08-17
PT83389A (en) 1986-10-01
CN1013198B (zh) 1991-07-17
ES2001698A6 (es) 1988-06-01
UA5953A1 (uk) 1994-12-29

Similar Documents

Publication Publication Date Title
HK88692A (en) Sulfonyl ureas with anti-tumour activity
ZA861179B (en) Oximeter
EP0264348A3 (en) Ureas
GB8618107D0 (en) Catalysts
GB8508777D0 (en) Roof structure
ZA862322B (en) Novel benzoylureas
GB8603223D0 (en) Substituted phenylurea
EP0159966A3 (en) Sulfonyl ureas
GB8625654D0 (en) Catalysis
GB8528194D0 (en) Roofs
GB2195641B (en) Polypeptide with interleukin-2 activity
GB8519223D0 (en) Catalysts
GB8622841D0 (en) Ruler
GB8507691D0 (en) Catalysts
IE853079L (en) Ureas.
IE841907L (en) Ureas
GB8528108D0 (en) Catalysis
GB8625655D0 (en) Catalysis
GB8528109D0 (en) Catalysis
GB8510125D0 (en) Circle ruler
CA55406S (en) Ruler
IE851128L (en) Sulfonylureas
IE852078L (en) N-(heterocyclyloxyphenyl) ureas
IE851142L (en) Roof structure
GB8503472D0 (en) Roof structure